The designation is given for producing research, not for applying it. Western protocols are frequently too costly or too impractical for the conditions most Indian children are treated in. ICMR recognised a department building indigenous, resource-optimised answers instead: affordable surgical techniques, cheaper catheter methods, screening tools designed for a health worker rather than a laboratory.

It rests on output, not standing. Fourteen major grant-funded research projects have been executed here and more than 250 papers published, over 120 of them in international peer-reviewed journals, with a dedicated research office running studies funded by ICMR and the Department of Science and Technology.

ICMR centres sit close to policy. The genetic research, surgical protocols and epidemiological data produced at a Collaborating Centre of Excellence feed into national public health guidance. When a state or national programme needs to decide how congenital heart disease should be screened for or treated at scale, this is one of the places the evidence comes from. A partner funding work here is contributing to the clinical models that shape government health policy, not only to the children treated in one building.

The standard of oversight is the point. ICMR holds these centres to rigorous requirements on scientific integrity, peer-reviewed data audit and clinical transparency. That is a form of institutional accountability a partner can rely on without having to construct it themselves.

Funding a hospital treats the children who reach it. Funding a research centre changes what is possible for the children who do not.

The designation is audited, not awarded on reputation. A centre must submit to multi-year clinical review and demonstrate that its surgical survival rates hold against the standards of programmes in the United States and the United Kingdom.

It carries an obligation as well as a title. A Centre of Excellence is expected to act as a regional training hub and to build paediatric cardiac capacity in other hospitals. That is why surgeons, cardiologists and intensive care specialists from across South Asia and Africa have come here to be taught rather than only sending patients.

For a partner, funding does not stop at one operation in Kochi. It reaches the specialists who will go on to treat children in hospitals this department will never own.

Self-reported outcomes are worth very little. Any programme can publish a survival figure. What makes a figure meaningful is that a third party collected it, defined the terms, and compared it against the same measures at other centres. IQIC does all three, and has done so here without interruption.

The comparison is deliberately hard. The collaborative benchmarks congenital heart surgery in centres outside high-income countries, which means the case mix includes children who present late, underweight and with pulmonary hypertension already established.

For a partner required to commission an independent impact assessment, the measurement framework already exists, is externally run, and predates the partnership.